-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on Ionis Pharmaceuticals, Raises Price Target to $100

Benzinga·01/05/2026 18:45:40
語音播報
Wells Fargo analyst Yanan Zhu maintains Ionis Pharmaceuticals (NASDAQ:IONS) with a Overweight and raises the price target from $82 to $100.